Journal of Clinical Apheresis

Papers
(The median citation count of Journal of Clinical Apheresis is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue162
Direct hemoperfusion using a polymyxin B‐immobilized polystyrene column for COVID‐1929
Ninety days transplant free survival with high volume plasma exchange in Wilson disease presenting as acute liver failure24
Efficacy of convalescent plasma therapy for COVID‐19: A systematic review and meta‐analysis19
Refractory vaccine‐induced immune thrombotic thrombocytopenia (VITT) managed with delayed therapeutic plasma exchange (TPE)18
Rapid reduction in triglyceride levels by therapeutic plasma exchange in patients with hypertriglyceridemic pancreatitis18
Effect of TPE vs medical management on patient outcomes in the setting of hypertriglyceridemia‐induced acute pancreatitis with severely elevated triglycerides16
The use of therapeutic plasma exchange as adjunctive therapy in the treatment of coronavirus disease 2019: A critical appraisal of the current evidence14
Immunoadsorption and plasma exchange—Efficient treatment options for neurological autoimmune diseases14
A matched cohort study of convalescent plasma therapy for COVID‐1913
Immune checkpoint inhibitor toxicity: A new indication for therapeutic plasma exchange?12
Plasmapheresis compared with conventional treatment for hypertriglyceridemia‐induced acute pancreatitis: A systematic review and meta‐analysis11
Incidence, diagnosis, and outcome of immune‐mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpura10
Initial experience with high‐volume plasma exchange in patients with acute liver failure10
Special Issue Abstracts from the American Society for Apheresis 44th Annual Meeting April 26–28, 202310
Biomarker profile predicts clinical efficacy of extracorporeal photopheresis in steroid‐resistant acute and chronic graft‐vs‐host disease after allogenic hematopoietic stem cell transplant10
Therapeutic plasma‐exchange improves short‐term, but not long‐term, outcomes in patients with acute‐on‐chronic liver failure: A propensity score‐matched analysis9
Therapeutic plasma exchange and dextran‐sulfate plasma adsorption as extracorporeal treatments of extremely preterm preeclampsia with fetal growth restriction9
Parasite burden and red blood cell exchange transfusion for babesiosis9
Efficacy of therapeutic plasma exchange in patients with Crimean‐Congo hemorrhagic fever9
“Plasma exchange in a bottle”: An overview of efgartigimod for apheresis practitioners9
Hemostatic effects of therapeutic plasma exchange: A concise review8
Therapeutic plasma exchange is a safe and effective bridge therapy in patients with alcohol‐associated ACLF not having immediate prospects for liver transplantation—A case‐control, pilot st8
Peptide GAM immunoadsorption in anti‐PLA2R positive autoimmune membranous nephropathy. The PRISM trial8
Pediatric double positive anti‐glomerular basement membrane antibody and anti‐neutrophil cytoplasmic antibody glomerulonephritis—A case report with review of literature7
Lack of defined apheresis collection criteria in publicly available CAR‐T cell clinical trial descriptions: Comprehensive review of over 600 studies7
Stem cell mobilization in multiple myeloma patients relapsing after previous autologous hematopoietic stem cell transplantation: A multicenter report by the Polish Myeloma Study Group7
Abstract7
Therapeutic plasma exchange with albumin as a valuable method of preparing thyrotoxic patients for a life‐saving thyroidectomy7
Peripheral blood stem cell collection in children with extremely low body weight (≤8 kg). What have we learned over the past 25 years and where are the limits?7
Therapeutic plasma exchange in patients with sepsis: Secondary analysis of a cluster‐randomized controlled trial7
Neonatal Fc receptor blockade as emerging therapy in diseases with plasma exchange indications7
Tolerance and complications of therapeutic plasma exchange by centrifugation: A single center experience7
Therapeutic plasma exchange for the treatment of refractory necrotizing autoimmune myopathy7
Comparison of three modalities of plasmapheresis on coagulation: Centrifugal, single‐membrane filtration, and double‐filtration plasmapheresis6
Treatment of refractory myasthenia gravis by double‐filtration plasmapheresis and rituximab: A case series of nine patients and literature review6
Double filtration plasmapheresis in hypertriglyceridemic pancreatitis: Triglyceride levels and clinical outcomes6
Source plasma deferral trends: A 3‐year analysis of 255 centers in the United States6
The first pediatric case of hemophagocytic lymphohistiocytosis secondary to Crimean‐Congo haemorrhagic fever successfully treated with therapeutic plasma exchange accompanying ribavirin and6
Role of extracorporeal photopheresis in the management of children with graft‐vs‐host disease6
Description of parallel and sequential configurations for concurrent therapeutic plasma exchange and continuous kidney replacement therapy in adults5
Immunogenic and immunotolerogenic effects of extracorporeal photopheresis in high immunological risk kidney recipients. A single center case series5
Outcome of desensitization in human leukocyte antigen and ABO incompatible living donor kidney transplantation: Single center experience of first 200 incompatible transplants5
Assessing efficacy and safety of replacement fluids in therapeutic plasma exchange: A systematic scoping review of outcome measures used5
Analysis of laboratory parameters for optimal autologous peripheral blood stem cell collection from lymphoma and myeloma patients5
Comparison of centrifugal and membrane filtration modalities on therapeutic plasma exchange5
Therapeutic plasma exchange for peripheral neuropathy associated with trisulfated heparan disaccharide IgM antibodies: A case series of 17 patients5
Cardiovascular events in patients with familial hypercholesterolemia and hyperlipoproteinaemia (a): Indications for lipoprotein apheresis in Poland5
Ultrasound‐based criteria for adequate peripheral venous access in therapeutic apheresis procedures5
Novel use of a midline catheter for therapeutic and donor apheresis in children and adults5
Patients with hereditary hemochromatosis reach safe range of transferrin saturation sooner with erythrocytaphereses than with phlebotomies5
Application of the French TMA Reference Center Score and the mortality in TTP Score in de novo and relapsed episodes of acquired thrombotic thrombocytopenic purpura at4
Concomitant pharmacologic medications influence the clinical outcomes of granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis: A multicenter retrospective cohort study4
Apheresis medicine in the era of advanced telehealth technologies: An American Society for Apheresis position paper part II: Principles of apheresis medical practice in a 21st century electronic medic4
Therapeutic plasmapheresis for the treatment of thyrotoxicosis: A retrospective multi‐center study4
Correlation between peripheral blood automated hematopoietic progenitor cell counts and flow cytometric CD34+ cell counts differs according to diagnosis in patients undergoing au4
Isoagglutinin removal by plasma centrifugation or filtration (single or double): A prospective study in a single center4
Membrane‐based therapeutic plasma exchange: Hemodynamics and operational characteristics leading to procedure failure4
Clinical experience with maintenance therapeutic plasma exchange in refractory generalized myasthenia gravis4
Efficacy of peripheral arterial access for peripheral blood stem cells collection4
Therapeutic plasma exchange for steroid refractory idiopathic inflammatory myopathies with interstitial lung disease4
Rheopheresis for severe peripheral arterial disease in hemodialysis patients: A clinical series4
Exogenous insulin antibody syndrome treated with plasma exchange after an incomplete response to immunosuppressive therapy4
Use of therapeutic plasma exchange in heparin‐induced thrombocytopenia: A population‐based study4
Analysis of 52 240 source plasma donors of convalescent COVID‐19 plasma: Sex, ethnicity, and age association with initial antibody levels and rate of dissipation4
Severe complications in a 25‐year‐old male after brown recluse spider bite treated by therapeutic plasma exchange: A case report and review of other case studies4
Early is superior to late plasma exchange for severe multisystem inflammatory syndrome in children4
Fibrinogen reconstitution after therapeutic apheresis: Comparison of double‐filtration plasmapheresis, plasma exchange, and immunoadsorption3
Race/ethnicity and underlying disease influences hematopoietic stem/progenitor cell mobilization response: A single center experience3
Positive effects of ultrasound‐guided peripheral IV insertion on pediatric sickle cell anemia/thalassemia patients receiving automated red cell exchange procedures or chronic tra3
Efficacy of intravenous combined immunosuppression with plasmapheresis in adult patients with refractory primary focal segmental glomerulosclerosis3
Adsorptive granulomonocytapheresis alters the gut bacterial microbiota in patients with active ulcerative colitis3
Cost saving, patient centered algorithm for progenitor cell mobilization for autologous hematopoietic cell transplantation3
Infectious risks in patients treated with extracorporeal photopheresis for graft‐versus‐host disease: A retrospective cohort study3
Mobilized and apheresis‐collected endothelial progenitor cells with plerixafor3
Outcome of extracorporeal photopheresis in mycosis fungoides patients is not predicted by quotients of systemic immune‐inflammatory biomarkers3
Treatment of comatose patient from cyclobenzaprine overdose with therapeutic plasma exchange3
The impact of delayed and immediate adverse events on the intention of future donations in whole blood and plateletpheresis donors3
Early response to caplacizumab and rituximab after anaphylaxis to Octaplas plasma in a patient with thrombotic thrombocytopenic purpura3
Further evidence for the benefit of therapeutic plasma exchange for acute multi‐organ failure syndrome refractory to red cell exchange in sickle cell disease3
Safe peripheral blood stem cell collection in patients less than 10 kg: A single‐center review3
A case of severe DRESS syndrome treated with therapeutic plasma exchange and intravenous immunoglobulin therapy3
Nationwide practices in the use of central venous catheters for therapeutic plasma exchange in the inpatient setting3
Addition of plerixafor in poorly mobilized allogeneic stem cell donors3
Therapeutic plasma exchange: A potential therapeutic modality for critically ill adults with severe acute respiratory syndrome coronavirus 2 infection3
Efficacy of plasmapheresis and semi‐selective immunoadsorption for removal of anti‐HLA antibodies3
The role of treatment with plasma exchange therapy in two pediatric toxic epidermal necrolysis cases related to COVID‐193
Is absence of CD56 a predictive factor for peripheral blood stem cell mobilization failure in patients with multiple myeloma?3
Plerixafor added to G‐CSF allows mobilization of a sufficient number of hematopoietic progenitors without impacting the efficacy of TCR‐alpha/beta depletion in pediatric haploide3
Impact of the number of cryopreserved CD34+ cells in the infused blood grafts on hematologic recovery and survival in myeloma patients after autologous stem cell transplantation:3
Treatment of antibody‐mediated rejection with double‐filtration plasmapheresis, low dose IVIg plus rituximab after kidney transplantation3
Hematopoietic progenitor cell counting can optimize peripheral blood stem cell apheresis process3
Autologous hematopoietic stem cell product contaminated with Salmonella due to occult salmonellosis in an asymptomatic donor3
Comparison of hematopoietic progenitor cell collection using different inlet flow rates with the Fenwal Amicus2
Retrospective analysis comparing complication rates of centrifuge vs membrane‐based therapeutic plasma exchange in the pediatric population2
Comparison of procedure times and collection efficiencies using integrated and multistep nonintegrated procedures for extracorporeal photopheresis2
Regional citrate anticoagulation vs systemic heparin anticoagulation for double‐filtration plasmapheresis2
Writing scientific case reports for top‐line journals2
Effect on haemostasis of different replacement fluids during therapeutic plasma exchange—A comparative multicentre observational study2
A predictive model for estimating the number of erythrocytapheresis or phlebotomy treatments for patients with naïve hereditary hemochromatosis2
The impact of the COVID‐19 pandemic on source plasma donations2
Immunoadsorption in a dog with severe immune mediated hemolytic anemia2
Apheresis Illustrated. Hyper‐triglyceridemic acute pancreatitis: A milky situation2
The report from ASFA COVID‐19 taskforce: Considerations and prioritization on apheresis procedures during the SARS‐CoV‐2 coronavirus disease (COVID‐19) pandemic2
Extracorporeal photopheresis vs standard therapies for steroid‐refractory chronic graft‐vs‐host disease: Pharmacoeconomic assessment of hospital resource use in Spain2
A prospective study on tryptophan immunoadsorption in AQP4 antibody‐positive neuromyelitis optica spectrum disorders2
Safety and performance of theSpectraOptia apheresis system for white blood cell depletion in patients with elevated white blood cell counts2
Donor tolerability of convalescent plasma donation2
Is split‐dose better than single‐dose? Results of Turkish Stem Cell Coordination Center (TURKOK) donors in the era of rising biosimilar G‐CSF2
Apheresis practice patterns in the United States of America: Analysis of a market claims database2
2
Successful treatment of pure red cell aplasia using therapeutic plasma exchange after ABO‐incompatible hematopoietic stem cell transplant2
Implications of CAR‐T cell therapy on apheresis services: a Scottish perspective2
Increased serum pro‐B‐type natriuretic peptide in hematopoietic progenitor cell donors stimulated with G‐CSF2
Efficacy and cost of double filtration plasmapheresis in severe hypertriglyceridemia‐induced pancreatitis: A retrospective observational study2
Ethylene oxide‐type hypersensitivity reactions in G‐CSF mobilized, peripheral blood hematopoietic progenitor cell donors and review2
Successful treatment with immunoadsorption therapy in four patients with severe and refractory anti‐N‐methyl‐D‐aspartate receptor encephalitis2
Successful stem cell collection for atypical teratoid rhabdoid tumor in an extremely low‐body weight child: A case report2
The first reported use of red blood cell exchange to treat hemoglobin Evans with secondary methemoglobinemia2
Recovery of Symmetrical Peripheral Gangrene of Limbs in a Patient After Performing Hemoadsorption in Septic Shock2
Impact of Covid‐19 on the therapeutic plasma exchange service within the South East Asian region: Consensus recommendations and global perspectives2
Successful treatment with therapeutic plasmapheresis of a pediatric patient with Guillain‐Barré syndrome associated with neurobrucellosis2
Central venous catheters are associated with thrombosis among adult inpatients undergoing therapeutic plasma exchange2
Therapeutic plasma exchange practices in immune thrombocytopenia related hospitalizations: Results from a nationally representative sample2
Role of automated red blood cell exchange in the treatment of aluminum phosphide poisoning: A case report and review of the literature2
Lessons relearned: Peripheral IV placement and recirculation2
Establishing low‐density lipoprotein apheresis tolerability in patients with prior anaphylactoid reactions to lipoprotein apheresis using magnesium sulfate2
Extracorporeal photopheresis and multimodality therapy in patients with T‐cell cutaneous lymphomas: Real‐life experience in Argentina2
Peripheral blood stem cells collection by apheresis in very low‐weight children with malignant diseases—A single center experience2
Failure of double filtration plasmapheresis to treat severe pemphigus vulgaris: A case report2
Rapid development of a de novo convalescent plasma program in response to a global pandemic: A large southeastern U.S. blood center's experience2
Are we choosing mobilization regimens for autologous stem cell transplantation in multiple myeloma wisely: A single center comparison of GCSF+/−plerixafor vs cyclophosphamide/GCSF2
1
Analysis of responses of the health care workers recovered from COVID‐19 on convalescent plasma donation by apheresis: A single‐center survey study1
1
Low‐density lipoprotein apheresis for recurrent focal segmental glomerulosclerosis post renal transplant in pediatric patients1
In situ off‐line extracorporeal photopheresis conducted in a real‐life situation at a Hemobiotherapy Department in France: A comparison of costs vs on‐line procedure1
The pro‐B‐type natriuretic peptide dilemma in hematopoietic progenitor cell collection1
Telapheresis: A new paradigm for “saw and evaluated”1
A nationwide population‐based study on therapeutic plasma exchange for 10 years in Korea using Health Insurance Review and Assessment database1
Total nucleated cell dose in graft is a better prognostic factor for survival in pediatric patients transplanted with bone marrow compared to CD34+, CD3+, or total mononuclear ce1
Effects of central catheter recirculation during extracorporeal photopheresis1
Evaluation of safety of using incompatible plasma for therapeutic plasma exchange during shortage of AB plasma1
High D‐index during mobilization predicts poor mobilization ofCD34+ cells after anti‐lymphoma salvage chemotherapy1
Therapeutic plasma exchange in adolescent and adult patients with autoimmune neuropsychiatric disorders associated with streptococcal infections1
Tandem hemodialysis and DFPP: Procedure, safety and cost‐effectiveness in patients requiring chronic hemodialysis and lipid apheresis1
Large volume plasmapheresis using a single‐use immunoadsorption column: A cost‐effective approach for desensitization in ABO‐incompatible liver transplant1
Efficient removal of antibodies to adeno‐associated viruses by immunoadsorption1
Comprehensive guide to managing a chronic automated red cell exchange program in sickle cell disease1
1
Pseudohemolysis during therapeutic plasma exchange due to IV iron dextran therapy1
Algorithm‐based selection of automated red blood cell exchange procedure goals reduces blood utilization in chronically transfused adults with sickle cell disease1
Therapy plans for therapeutic apheresis in Epic HealthLink1
Favorable recovery profiles and good reliability among youngest unrelated stem cell donors supports lowering the minimum donor registration age1
Cost comparison of extracorporeal photopheresis technologies at the European Institute of Oncology1
Development and validation of a nomogram for predicting the risk of vasovagal reactions after plasma donation1
Is a 20 gauge fenestrated intravenous catheter non‐inferior to a 18 gauge standard catheter for apheresis procedures? A pilot study1
Google Trends demonstrate public interest in COVID‐19 convalescent plasma therapy1
Therapeutic plasma exchange decreases plasma anti‐SARS‐CoV‐2 spike IgG without increasing the proximate incidence of COVID‐191
Investigation on the feasibility of large‐volume autologous red blood cells donation: A pilot trial in a small cohort of Chinese1
Comorbidity in lipoprotein apheresis: Their role in the era of new lipid‐lowering therapies1
Therapeutic plasma exchange provides native liver survival benefit in children with acute liver failure: A propensity score‐matched analysis1
COVID‐19‐associated transverse myelitis treated by therapeutic plasma exchange: A case report1
Botulism mimicking Guillain‐Barre syndrome: The question of plasma exchange in an unusual case of acute paralysis1
Hemoglobin S target of <50% as compared to 30% in chronic red cell exchange for secondary stroke prevention in sickle cell disease1
Therapeutic plasma exchange for life‐threatening pediatric disorders1
Navigating the neutropenic abyss with granulocyte transfusions: Retrospective single‐center analysis of effectiveness and safety in India1
How to improve clotting factors depletion in double‐filtration plasmapheresis1
Therapeutic plasma exchange for mechanical red cell hemolysis: A case series1
Assessing the clinical efficacy of low‐volume therapeutic plasma exchange in achieving recovery from acute liver failure induced by yellow phosphorous poisoning1
Therapeutic plasma exchange in patients with severe obesity (BMI >40): A survey of practices in the United States1
No increase in anti‐A isohemagglutinin titer after SARS‐CoV‐2 infection: A retrospective cohort analysis of group O apheresis platelet donors1
Therapeutic plasma exchange in the intensive care unit and with the critically ill, a focus on clinical nursing considerations1
A validation and modification of PLASMIC score by adjusting the criteria of mean corpuscular volume and international normalized ratio1
Hyperchloremic metabolic acidosis after plasma exchange in a patient with renal transplant rejection: A case report1
Manipulating the complement system via Therapeutic plasmapheresis: Is there any therapeutic role?1
Mobilization with high‐dose granulocyte colony‐stimulating factor alone at 12 μg/kg twice a day in high‐risk pediatric patients: A retrospective analysis of the experience in a single center1
Rapidly lowering triglyceride levels by plasma exchange in acute pancreatitis: What's the point?1
Two acute psychiatric emergencies and prevalence of mental health disorders at an outpatient apheresis clinic: Implications for apheresis practitioners1
A single center retrospective study: Comparison between centrifugal separation plasma exchange with ACD‐A and membrane separation plasma exchange with heparin on acute liver failure and acu1
Therapeutic plasma exchange in a patient with acute motor axonal neuropathy subtype of Guillain‐Barre syndrome and systemic lupus erythematosus1
Baseline inflammation indexes and neutrophil‐to‐LDH ratio for prediction of the first mobilization failure without plerixafor‐based regimens in multiple myeloma and lymphoma patients: A sin1
MicroRNA and granulocyte‐monocyte adsorption apheresis combotherapy after inadequate response to anti‐TNF agents in ulcerative colitis1
Massive bee envenomation treated by therapeutic plasma exchange1
Feasibility, safety, and tolerability of two modalities of plasma exchange with albumin replacement to treat elderly patients with Alzheimer's disease in the AMBAR study1
Successful “on‐demand” plerixafor for autologous peripheral blood stem‐cells transplantation for relapsed/refractory germ cell tumors1
Validation of Nivestym compared to Neupogen: An NMDP analysis1
Effectiveness of leukapheresis on early survival in acute myeloid leukemia: An observational propensity score matching cohort study1
Platelet decrease and efficacy of platelet‐rich plasma return following peripheral blood stem cell apheresis1
Abstract1
A Saudi multicenter experience on therapeutic plasma exchange for patients with thrombotic thrombocytopenic purpura: A call for national registry1
Primed for change: The effect of a blood prime on peripheral blood stem cell collection and accuracy of a prediction tool in pediatric patients1
Impact of saline infusion as replacement fluid at donor plasmapheresis1
The utility of therapeutic plasma exchange in Hyperviscosity syndrome associated with juvenile rheumatoid arthritis: A case report1
0.11065578460693